Constellation Pharmaceuticals Advances CPI-0209 into Clinical Trials, Expanding its EZH2 Franchise Portfolio News / admin September 24, 2019 Constellation Pharmaceuticals Advances CPI-0209 into Clinical Trials, Expanding its EZH2 Franchise Read More »
REVOLUTION Medicines Announces Dosing of First Patient in RMC-4630-02, a Phase 1b/2 Trial Combining RMC-4630 with a MEK Inhibitor Portfolio News / admin September 17, 2019 REVOLUTION Medicines Announces Dosing of First Patient in RMC-4630-02, a Phase 1b/2 Trial Combining RMC-4630 with a MEK Inhibitor Read More »
Ribon Therapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of RBN-2397, a First-In-Class PARP7 Inhibitor Portfolio News / admin September 4, 2019 Ribon Therapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of RBN-2397, a First-In-Class PARP7 Inhibitor Read More »
Kallyope Inc. Appoints Juha Lauren as Chief Business Officer Portfolio News / admin September 4, 2019 Kallyope Inc. Appoints Juha Lauren as Chief Business Officer Read More »
Ribon Therapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of RBN-2397, a First-In-Class PARP7 Inhibitor Portfolio News / admin September 4, 2019 Ribon Therapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of RBN-2397, a First-In-Class PARP7 Inhibitor Read More »
Accent Therapeutics Appoints Shakti Narayan as Chief Executive Officer Portfolio News / admin September 3, 2019 Accent Therapeutics Appoints Shakti Narayan as Chief Executive Officer Read More »